Perceptive Advisors LLC Acumen Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

  • $3 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$4.81 - $10.17 $252,765 - $534,433
-52,550 Reduced 13.14%
347,450 $1.88 Million
Q3 2022

Nov 14, 2022
SELL
$4.44 - $10.48 $481,882 - $1.14 Million
-108,532 Reduced 21.34%
400,000 $4.01 Million
Q2 2022

Aug 15, 2022
SELL
$3.08 - $4.88 $272,302 - $431,440
-88,410 Reduced 14.81%
508,532 $2.39 Million
Q1 2022

May 16, 2022
BUY
$3.91 - $6.73 $2.33 Million - $4.02 Million
596,942 New
596,942 $2.33 Million

Others Institutions Holding ABOS

# of Institutions
81
Shares Held
40.6M
Call Options Held
28.6K
Put Options Held
76.4K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $48.6M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email